sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
ENT and Bronchoscopy Devices Market by Product (Endoscopes, Surgical ENT & Bronchoscopy Devices, and Hearing Care Devices) and End User (Hospitals & Clinics, Home Use, and Ambulatory Surgical Centers (ASCs)) - Global Opportunity Analysis and Industry Forecast, 2014-2022

ENT and Bronchoscopy Devices Market by Product (Endoscopes, Surgical ENT...

Home / Categories / Healthcare
ENT and Bronchoscopy Devices Market by Product (Endoscopes, Surgical ENT & Bronchoscopy Devices, and Hearing Care Devices) and End User (Hospitals & Clinics, Home Use, and Ambulatory Surgical Centers (ASCs)) - Global Opportunity Analysis and Industry Forecast, 2014-2022
ENT and Bronchoscopy Devices Market...
Report Code
RO1/113/1136

Publish Date
01/Mar/2017

Pages
259
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Growing incidence of hearing and nasal disorders
3.4.1.2. Technological advancements
3.4.1.3. Growing geriatric population
3.4.1.4. Increase in patient preference for minimally invasive procedures

3.4.2. Restraints

3.4.2.1. High cost of devices
3.4.2.2. Dearth of skilled professionals

3.4.3. Opportunities

3.4.3.1. Lucrative opportunities in the emerging economies
3.4.3.2. High demand for cosmetic ENT procedures

3.4.4. Impact analysis

3.5. CLINICAL TRIALS

CHAPTER 4 ENT & BRONCHOSCOPY DEVICES MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ENDOSCOPES

4.2.1. Rigid endoscopes

4.2.1.1. Otoscopes
4.2.1.2. Sinuscopes

4.2.2. Flexible endoscopes

4.2.2.1. Laryngoscopes
4.2.2.2. Pharyngoscopes
4.2.2.3. Rhinoscopes
4.2.2.4. Nasopharyngoscopes

4.2.3. Hearing screening devices
4.2.4. Bronchoscopes
4.2.5. Key market trends
4.2.6. Key growth factors and opportunities
4.2.7. Market size and forecast

4.3. SURGICAL ENT & BRONCHOSCOPY DEVICES

4.3.1. Powered surgical instruments
4.3.2. Radiofrequency devices
4.3.3. Handheld instruments

4.3.3.1. Rhinology instruments
4.3.3.2. Otology instruments
4.3.3.3. Laryngeal instruments
4.3.3.4. Head and neck surgical instruments
4.3.3.5. Other handheld instruments

4.3.4. Balloon sinus dilation devices
4.3.5. Nasal splints & stents
4.3.6. Bronchial/tracheal stents
4.3.7. Ear tubes
4.3.8. ENT lasers
4.3.9. Image-guided surgery systems
4.3.10. Key market trends
4.3.11. Key growth factors and opportunities
4.3.12. Market size and forecast

4.4. HEARING CARE DEVICES

4.4.1. Hearing aids

4.4.1.1. Behind-the-ear (BTE) aids
4.4.1.2. In-the-ear aids
4.4.1.3. Receiver-in-the-ear (RITE)
4.4.1.4. Canal hearing aids

4.4.2. Hearing implants

4.4.2.1. Cochlear implants
4.4.2.2. Bone-anchored hearing systems (BAHS)
4.4.2.3. Auditory brainstem implants
4.4.2.4. Middle ear implants

4.4.3. Key market trends
4.4.4. Key growth factors and opportunities
4.4.5. Market size and forecast

CHAPTER 5 ENT & BRONCHOSCOPY DEVICES MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS & CLINICS

5.2.1. Market size and forecast

5.3. HOME-USE

5.3.1. Market size and forecast

5.4. AMBULATORY SURGICAL CENTERS (ASCS)

5.4.1. Market size and forecast

CHAPTER 6 ENT & BRONCHOSCOPY DEVICES MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S.
6.2.5. Canada
6.2.6. Mexico

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany
6.3.5. France
6.3.6. UK
6.3.7. Italy
6.3.8. Spain
6.3.9. Rest of Europe

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan
6.4.5. China
6.4.6. India
6.4.7. South Korea
6.4.8. Australia
6.4.9. Rest of Asia-Pacific

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil
6.5.5. South Africa
6.5.6. Saudi Arabia
6.5.7. Rest of LAMEA

CHAPTER 7 COMPANY PROFILES

7.1. COCHLEAR LIMITED

7.1.1. Overview
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. ENTELLUS MEDICAL, INC.

7.2.1. Company overview
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. GN STORE NORD A/S

7.3.1. Overview
7.3.2. Operating business segments
7.3.3. Business performance
7.3.4. Key strategic moves and developments

7.4. HOYA CORPORATION (PENTAX MEDICAL)

7.4.1. Company overview
7.4.2. Operating business segments
7.4.3. Business performance
7.4.4. Key strategic moves and developments

7.5. JOHNSON & JOHNSON

7.5.1. Overview
7.5.2. Operating business segments
7.5.3. Business performance
7.5.4. Key strategic moves and developments

7.6. KARL STORZ GMBH & CO. KG

7.6.1. Company overview
7.6.2. Operating business segments
7.6.3. Business performance
7.6.4. Key strategic moves and developments

7.7. MED-EL

7.7.1. Overview
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. MEDTRONIC PLC

7.8.1. Company Overview
7.8.2. Operating business segments
7.8.3. Business performance

7.9. OLYMPUS CORPORATION

7.9.1. Company overview
7.9.2. Operating business segments
7.9.3. Business performance
7.9.4. Key strategic moves and developments

7.10. SIVANTOS PTE. LTD.

7.10.1. Overview
7.10.2. Business performance
7.10.3. Key strategic moves and developments

7.11. SMITH & NEPHEW PLC.

7.11.1. Company overview
7.11.2. Operating business segments
7.11.3. Business performance

7.12. SONOVA HOLDING AG

7.12.1. Overview
7.12.2. Operating business segments
7.12.3. Business Performance
7.12.4. Key strategic moves and developments

7.13. WILLIAM DEMANT HOLDING A/S

7.13.1. Overview
7.13.2. Operating business segments
7.13.3. Business performance

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com